Real-time enrollment status for this heart failure clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 12:45 AM UTC
| NCT Number | NCT06307652 |
| Recruiting Status | Recruiting |
| Condition | Heart Failure |
| Phase | PHASE3 |
| Target Enrollment | 3,850 participants |
| Active Locations | 166 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | October 13, 2026 (3 days ago) |
As of October 16, 2026: Clinical trial NCT06307652 is currently recruiting participants. This phase3 study for heart failure is actively seeking new participants at 166 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06307652 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 166 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06307652 was last updated 3 days ago (October 13, 2026). HelloStudys verifies this status automatically.